Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleosome assembly protein 1-like 1 pseudogene 2 (NAP1L1P2) is a pseudogene in the human genome, annotated as a nonfunctional sequence similar to the functional NAP1L1 gene, which encodes a histone chaperone involved in nucleosome assembly[1][4][5]. Pseudogenes like NAP1L1P2 are characterized by their resemblance to protein-coding genes, but they have accumulated mutations (such as frameshifts or premature stop codons) that prevent them from producing a functional protein product[2][3]. While some pseudogenes may have regulatory roles at the RNA level (e.g., as decoys for microRNAs or sources of noncoding RNAs), there is no specific evidence that NAP1L1P2 has such functions or disease associations[1][3]. As such, it is not considered a therapeutic target, receptor, enzyme, or a molecule of clinical interest for drug development. Note: This entry is considered “incorrect” for a typical therapeutic target list because it is a pseudogene and does not produce a functional protein or have a validated direct biological activity or druggability[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome assembly protein 1-like 1 pseudogene 2 (NAP1L1P2).